ACAM-CDIFF regulatory update

sanofi-aventis disclosed in its 3Q10 earnings that FDA granted Fast Track designation for its ACAM-CDIFF vaccine against Clostridium difficile infection. The vaccine is in Phase IIb testing for the in...